Cancer immunotherapy has completely changed our understanding of how cancer can and should be treated. A prime example is chimeric antigen receptor (CAR) T-cell therapy, where T cells are harvested ...

A personal reflection on the promise and limits of CAR T therapy—its breakthroughs, failures, scientific bottlenecks, and what must change to truly save more lives.

Scientists identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies. Researchers at Sylvester Comprehensive Cancer Center at the University of ...

When treatments such as chemotherapy falter, the uncontrolled expansion of B cells can be quelled by CAR T therapy. This recent innovation often achieves long term remission of B cell cancers, ...

The ongoing coronavirus disease 2019 (COVID-19) pandemic has led to over 6.4 million deaths, with fresh cases continuing to emerge. With the widespread vaccination drives, the spread of the virus was ...

Please provide your email address to receive an email when new articles are posted on . Four of five patients with relapsed or refractory B-cell lymphoma demonstrated complete response to an ...

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with ...